Microfluidics Market Size & Share | Industry Growth by 2027

The microfluidics market size is estimated to reach US$ 43,398.7 million by 2027 from US$ 11,851.1 million in 2019; it is estimated to grow at a CAGR of 17.9% from 2019 to 2027.

Microfluidics involves various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. It is an emerging technology having a wide range of applications in biology, chemistry, optics, and information technology. This technology is widely used in techniques such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, and PCR amplification. Additionally, microfluidics is used in disease research and diagnosis. The microfluidics market growth is attributed owing to innovations in microfluidics products, high-throughput screening methodologies, in vitro diagnostics (IVD), and development of advanced lab-on-a-chip technologies. However, the lower adoption of these products in emerging economies may hinder the growth of the market.

Lucrative Regions for Microfluidics Market

Get more information on this report : Request Free Sample PDF

Market Insights

Innovation in Microfluidics Products

The increasing technological advancements in diagnostic devices and the rising incidence of chronic diseases are encouraging the adoption of microfluidics in disease diagnosis. The market is witnessing the launch of numerous technologically advanced products, such as 3D lab-on-a-chip devices. These advancements are leading to the evolution of a cost-effective mass-production of diagnostic devices in a wide range of diagnostic applications. Microfluidics have a potential role in creating accurate wearable technology. A recent study by the researchers showed that microchannels and micro reservoirs, pre-filled with fluorescent probes react to target analytes in sweat and can perform quantitative analysis. To capture sweat, fluorometric sensing modalities were integrated into a skin-interfaced microfluidic system paired with a smartphone-based imaging module. This method resulted in an accurate measurement of biomarkers in sweat. Researchers developed wearable sensors to monitor biomolecule levels by combining continuous fluid sampling with in-situ analysis. Depending upon the target biomolecule, the particular assay is interchangeable. The microfluidic device featured a droplet-flow method for timing and a micropump to produce nanolitre-sized droplets. Biomarker variations within fluids, over time, yield insight into tissue physiology and may help create personalized treatments for patients, thus resulting in better healthcare outcomes. Also, key market players have been introducing new products to strengthen their market position.

A few major product launches are mentioned below:

•     In February 2020, Miroculus, Inc. unveiled its Miro Canvas at the Advances in Genome Biology and Technology conference. The Miro Canvas system automates and miniaturizes complex protocols such as NGS library prep and improving library consistency. Also, it decreases sample input requirements and reagent volumes.

•     In January 2020, Nicoya launched the Alto surface plasmon resonance (SPR) system. It is a first fully-automated, high-throughput system that integrates digital microfluidics (DMF), artificial intelligence (AI), and nanotechnology. It offers high-quality, label-free interaction analysis. This product was designed to reduce the time and cost of drug discovery.

•     In November 2019, MicroMedicine, Inc. launched Sorterra Cell Isolation System. This new, patented automated technology isolates white blood cells from human peripheral blood using microfluidic channels without centrifugation or labeling.

Product-Based Insights

The global microfluidics market, based on product, is segmented into microfluidic chips, microfluidic sensors, devices, micropumps, microneedles, and other products. The devices segment held the largest share in 2019 and is expected to witness the highest growth from 2019 to 2027. The devices offer a vast variety of applications in many research areas and numerous benefits such as increased precision, shortened experiment time, and cost savings. Microfluidic devices exploit the physical and chemical properties of liquids and gases at a microscale. Microfluidic devices offer several advantages and benefits over conventionally sized systems. Microfluidics allows the analysis and use of less volume of samples, chemicals and reagents reducing the global fees of applications.

Material-Based Insights

The global microfluidics market, based on material, is segmented into PDMS, polymers, glass, silicon, and others. The PDMS segment held the largest share in 2019 and is expected to witness the fastest growth rate from 2019 to 2027. PDMS deformability permits easy connections of leak-proof fluidic connections, integration of fluidic valves through PDMS microchannels and is used to detect low forces such as biomechanics interactions from cells. The molding step allows mass-production of microfluidic chips from a mold. 

Application-Based Insights

The global microfluidics market, based on application, is segmented into in-vitro diagnostics, pharmaceutical and life science research, drug discovery, and other applications. The in-vitro diagnostics segment held the largest share in 2019 and is expected to witness the highest growth from 2019 to 2027. In vitro diagnostic (IVD) is an important component of clinical care, which contributes to the prevention, diagnosis, treatment, and management of diverse diseases by the analysis of biomolecules from body fluids, including proteins, nucleic acids, and small molecule metabolites

Strategic Insights

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the microfluidics market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The microfluidics market share is anticipated to flourish with the development of new innovative products by market players. Some of the companies that have been included in our research scope are Agilent Technologies, Inc.; BD; Bio-Rad Laboratories Inc.; Danaher; Dolomite Microfluidics (Blacktrace Holdings Ltd.); Fludigm Corporation; Illumina, Inc.; microfluidic ChipShop GmbH; Perkin Elmer, Inc.; Thermo Fisher Scientific Inc.; CMC Microsystems; Epigem; FlowJEM; Quidel Corporation; and Abaxis, Inc.